Summary
To determine whether adenosine is involved in long-term regulation of glucose transport in adipose tissue, we have investigated effects of administration of an adenosine receptor antagonist (theophylline) on adipocyte glucose transport. Rats were injected with theophylline (30 mg/kg, dissolved in 0.9% NaCl) daily for 7 days. Controls were injected with saline. The rats were then killed, and epididymal adipocytes were isolated. Insulin-stimulated glucose transport rates were decreased by about 25%–30% in the cells from theophylline-treated rats at all insulin concentrations tested. The half-maximally effective concentration of insulin was not altered (6.5±0.5 and 6.7±0.5 mU/l in control and treated cells respectively), suggesting a post-insulin binding defect. This was confirmed by the finding that 125I-insulin binding to the cells was not altered. Adenosine receptor number and affinity (measured on detergent-solubilized adipocyte extracts using 125I-hydroxyphenylisopropyl adenosine) was also not changed by theophylline treatment. We conclude that theophylline administration causes decreased glucose transport rates in rat adipocytes at a post-insulin binding level. Thus, chronic adenosine receptor blockade impairs adipocyte glucose transport, suggesting that adenosine is involved in long-term regulation of glucose metabolism in adipose tissue.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fredholm BB (1980) Are the effects of methyl xanthines due to antagonism of endogenous adenosine? Trends Pharm Sci 1: 129–132
Fredholm BB (1985) On the mechanism of action of theophylline and caffeine. Acta Med Scand 217: 149–153
Arch JRS, Newsholme EA (1979) The control of the metabolism and the hormonal role of adenosine. Essays Biochem 14: 82–123
Schwabe U, Ebert R, Erbler HC (1975) Adenosine release from fat cells: effects on cyclic AMP levels and hormone action. Adv Cyclic Nucleotide Res 5: 569–584
Schwabe U, Ebert R, Erbler HC (1973) Adenosine release from isolated fat cells and its significance for the effects of hormones on cyclic 3′, 5′-AMP levels and lipolysis. Naunyn-Schmiedeberg's Arch Pharmacol 276: 133–148
Kather H, Wieland E, Fischer B, Wirth A, Schlierf G (1985) Adrenergic regulation of lipolysis in abdominal adipocytes of obese subjects during caloric restriction: reversal of catecholamine action caused by relief of endogenous inhibition. Eur J Clin Invest 15: 30–37
Green A (1983) Glucagon inhibition of insulin-stimulated 2-deoxyglucose uptake by rat adipocytes in the presence of adenosine deaminase. Biochem J 212: 189–195
Green A, Bustillos DP, Misbin RJ (1984) Beta-hydroxybutyrate increases the insulin sensitivity of adipocyte glucose transport at a postreceptor level. Diabetes 33: 1045–1050
Schwabe U, Schönhöfer PS, Ebert R (1974) Facilitation by adenosine of the action of insulin on the accumulation of adenosine 3′: 5′-monophosphate, lipolysis and glucose oxidation in isolated fat cells. Eur J Biochem 46: 537–545
Fain JN, Wieser PB (1975) Effects of adenosine deaminase on cyclic adenosine monophosphate accumulation, lipolysis and glucose metabolism of fat cells. J Biol Chem 250: 1027–1034
Kather H, Bieger W, Michel G, Aktories K, Jakobs KH (1985) Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms. J Clin Invest 76: 1559–1565
Green A, Fisher M, Newsholme EA (1981) Maximum activities of enzymes involved in adenosine metabolism in adipose tissue of rats and mice under conditions of variation in insulin sensitivity. Biochim Biophys Acta 676: 125–128
Rodbell M (1964) Metabolism of isolated fat cells I: Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239: 375–380
Olefsky JM (1978) Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes. Biochem J 172: 137–145
Gliemann J (1985) Glucose transport and metabolism in the adipocyte: In: Lamer J, Pohl SL (eds) Methods in diabetes research, Vol I, Part C. John Wiley, New York, pp 105–118
Freychet P, Roth J, Neville DM Jr (1971) Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes. Biochem Biophys Res Commun 43: 400–408
Marshall S, Green A, Olefsky JM (1981) Evidence for recycling of insulin receptors in isolated rat adipocytes. J Biol Chem 256: 11464–11470
Schwabe U, Lenschow V, Ukena D, Ferry DR, Glossmann H (1982) [125I]N6-p-hydroxyphenylisopropyladenosine, a new ligand for Ri adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 321: 84–87
Linden J (1984) Purification and characterization of (-)[125I]hydroxyphenylisopropyladenosine, an adenosine R-site agonist radioligand and the theoretical analysis of mixed sterioisomer radioligand binding. Mol Pharmacol 26: 414–423
Burton K (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315–323
Fredholm BB (1982) Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol Scand 115: 283–286
Murray TF (1982) Up-regulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur J Pharmacol 82: 113–114
Kasuga M, Karlsson FA, Kahn CR (1982) Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215: 185–187
Kahn CR, White MF, Grigorescu F, Takayama S, Häring HU, Crettaz M (1985) The insulin receptor protein kinase. In: Czech MP (ed) Molecular basis of insulin action. Plenum Press, New York, pp 67–93
Wolff J, Londos C, Cooper DM (1981) Adenosine receptors and the regulation of adenylate cyclase. Adv Cyclic Nucleotide Res 14: 199–214
Daly JW (1983) Adenosine receptors: characterization with radioactive ligands. In: Daly JW, Kuroda Y, Phillis JW, Shimizu H, Ui M (eds) Physiology and pharmacology of adenosine derivatives. Raven, New York, pp 59–69
Fredholm BB (1984) Cardiovascular and renal actions of methyl xanthines. Prog Clin Biol Res 158: 303–330
Green A (1983) Catecholamines inhibit insulin-stimulated glucose transport in adipocytes, in the presence of adenosine deaminase. FEBS Lett 152: 261–264
Kobayashi M, Olefsky JM (1979) Effects of streptozotocin-induced diabetes on insulin binding, glucose transport and intracellular glucose metabolism in isolated rat adipocytes. Diabetes 28: 87–95
Kobayashi M, Olefsky JM (1978) Long-term regulation of adipocyte glucose transport capacity by circulating insulin in rats. J Clin Invest 62: 73–81
Fredholm BB (1984) Gastrointestinal and metabolic effects of methylxanthines. Prog Clin Biol Res 158: 331–354
Olefsky JM, Kolterman OG, Scarlett JA (1982) Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 243: E15-E30
Kolterman OG, Insel J, Saekow M, Olefsky JM (1980) Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 65: 1272–1284
Ohisalo JJ, Ranta S, Huhtaniemi IT (1986) Attenuated adenosine R-site effect in adipocytes in obesity. Metabolism 35: 143–146
Budohoski L, Challiss RA, McManus B, Newsholme EA (1984) Effects of analogues of adenosine and methyl xanthines on insulin sensitivity in soleus muscle of the rat. FEBS Lett 167: 1–4
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Green, A. Chronic administration of theophylline to rats induces a post-insulin binding defect in adipocyte glucose transport. Diabetologia 30, 188–192 (1987). https://doi.org/10.1007/BF00274226
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00274226